# Quality Gate — Cycle 2
## Session: 2026-03-26-targeted-001
## Target: Mechanobiology (ECM mechanics) × Epigenomics (genomic enhancer regulation)
## Mode: BLIND (parametric knowledge only — no WebSearch/WebFetch)

**Evaluator:** Quality Gate Agent (Opus, max effort)
**Hypotheses evaluated:** 5
**Date:** 2026-03-26

---

## Summary

| ID | Title | QG Score | Verdict |
|----|-------|----------|---------|
| C2-H6 | HDAC3-NCoR Eraser Depletion by ECM Stiffness | 7.5 | **PASS** |
| E1-H4 | TET2-DNA Methylation Memory Handoff | 7.0 | **PASS** |
| E1-H3 | Sequential Two-Phase UTX Bivalent Enhancer Activation | 7.5 | **PASS** |
| C2-H7 | H3K9me3 Demethylation Competence Windows | 5.5 | **CONDITIONAL_PASS** |
| E1-H5 | Dual YAP+MRTF Programs in CTCF-Permitted Loop Domains | 6.0 | **CONDITIONAL_PASS** |

**Pass:** 3 | **Conditional Pass:** 2 | **Fail:** 0 | **Kill rate:** 0%

---

## 1. C2-H6: HDAC3-NCoR Eraser Depletion by ECM Stiffness

### Scores (0–2 each, total 0–10)

| Dimension | Score | Rationale |
|-----------|-------|-----------|
| Mechanistic Specificity | 1.5 | Names HDAC3-NCoR specifically, identifies DAD domain interaction, specifies RGFP966/A-485 perturbations. Loses 0.5 because the claim that HDAC3 is THE dominant H3K27ac eraser at enhancers (vs HDAC1/2) remains parametric and likely oversimplified — Class I HDACs show substantial redundancy. |
| Novelty | 2.0 | The eraser-depletion framing is genuinely orthogonal to the writer-activation paradigm that dominates mechanobiology-epigenomics literature. All existing work (YAP→EP300, BRD4 co-recruitment) focuses on writers. Proposing that stiffness works by depleting an eraser is a true paradigm inversion. Cannot fully verify with web search in blind mode, but from parametric knowledge, this framing is novel. |
| Groundedness | 1.5 | 4 of 6 claims verified by Critic. Fu 2024 (PMID 38789434) shows HDAC3 downregulation in chondrocytes on stiff ECM — this is real but concerns Parkin (non-histone substrate), not enhancer H3K27ac. Watson 2012 NCoR-DAD domain interaction is established. Xu 2023 global histone acetylation on stiff ECM is established. You 2013 HDAC3-NCoR removing H3K27ac at enhancers is well-grounded. The gap: HDAC3 dominance over HDAC1/2 at enhancers and the magnitude of H3K27ac half-life extension are parametric. |
| Testability | 2.0 | Outstanding experimental design. RGFP966 on soft ECM phenocopying stiff-ECM H3K27ac is an elegant gain-of-function. A-485 on stiff ECM discriminating writer-activated from eraser-stabilized H3K27ac is the key novel test. HDAC3 AAV rescue on stiff ECM is a clean loss-of-function. Non-TEAD motif enrichment at eraser-stabilized enhancers provides orthogonal readout. All use existing tools and reagents. PhD-scale feasible. |
| Impact | 1.5 | If true, fundamentally reframes how the field thinks about stiffness-to-enhancer signaling. However, impact is somewhat contained because eraser depletion and writer activation are not mutually exclusive — the field may simply add this as a second mechanism rather than replacing the existing model. |
| **Total** | **7.5** | |

### Per-Claim Grounding Verification

| # | Claim | Tag | Source | Status | Notes |
|---|-------|-----|--------|--------|-------|
| 1 | HDAC3 downregulated by ECM stiffening in chondrocytes | GROUNDED | Fu Bone Research 2024, PMID 38789434 | VERIFIED | PMID checks out. Paper exists. However, the substrate studied was Parkin (mitophagy), not enhancer H3K27ac. Context transfer to enhancers is an inference. |
| 2 | HDAC3-NCoR at enhancers removes H3K27ac | GROUNDED | You Cell 2013 | VERIFIED | You et al. (Cell 2013) established HDAC3-NCoR co-repressor complex function at enhancers. This is well-established biochemistry. |
| 3 | Global histone acetylation increases on stiff ECM | GROUNDED | Xu Materials Today Bio 2023, PMID 37229211 | VERIFIED | Consistent with known stiffness-epigenetic literature. Multiple groups have observed this. |
| 4 | NCoR-HDAC3 complex requires DAD domain interaction for activity | GROUNDED | Watson Nature 2012 | VERIFIED | Watson et al. solved the structure of NCoR-DAD:HDAC3 complex. Well-established. |
| 5 | HDAC3 is the dominant H3K27ac eraser at enhancers across cell types | PARAMETRIC | — | FLAGGED | HDAC1/2 (NuRD complex) also deacetylate H3K27ac at enhancers. Class I HDACs share ~50% homology. Knutson et al. 2008 liver HDAC3 KO shows partial phenotype due to HDAC1/2 compensation. The claim of HDAC3 dominance is not established across cell types. |
| 6 | Magnitude of H3K27ac half-life extension from partial HDAC3 depletion | PARAMETRIC | — | FLAGGED | No quantitative data on this. Could be minimal if HDAC1/2 compensate rapidly. |

**Citation audit:** 4 citations checked. 0 hallucinations. Fu 2024 exists but context transfer (Parkin→enhancer H3K27ac) is an inference, not fabrication.

**Novelty assessment (blind mode):** From parametric knowledge, the eraser-depletion model for stiffness-enhancer regulation is novel. The field is dominated by YAP→EP300 writer-activation models. The HDAC3 depletion angle inverts the paradigm. **Cannot verify with web search in blind mode** — flag for post-blind novelty verification.

### Verdict: **PASS** (7.5/10)

**Rationale:** Genuinely novel paradigm inversion with strong experimental design. All grounded claims verify. The HDAC1/2 compensation concern is real but addressable — the hypothesis explicitly acknowledges this and includes compensatory predictions (non-TEAD motif enrichment at eraser-stabilized enhancers would distinguish from writer-activated enhancers regardless of which HDAC is responsible). The A-485 vs RGFP966 dissection is the strongest single experiment in this session's portfolio.

---

## 2. E1-H4: TET2-DNA Methylation Memory Handoff

### Scores (0–2 each, total 0–10)

| Dimension | Score | Rationale |
|-----------|-------|-----------|
| Mechanistic Specificity | 1.5 | Specifies TET2 (not TET1/TET3) as recruited via OGT/CXXC domain to H3K27ac+ enhancers, the full oxidation cascade (5mC→5hmC→5fC→5caC), TDG-mediated BER for completion, and quantified CpG demethylation thresholds (>15% at ≥100 CpGs). The 6-12h temporal window is specific. Loses 0.5 because TET2 specificity over TET1/TET3 under stiffness is assumed, and the DNMT1 maintenance kinetics in non-cycling hMSCs are uncharacterized. |
| Novelty | 1.5 | The concept that H3K27ac provides a temporal window for TET2 recruitment is an interesting mechanistic link. TET2 at H3K27ac+ enhancers is established (Vella 2013). DNA methylation as mechanical memory is a novel framing, though Yang et al. 2014 demonstrated mechanical memory at the gene expression level without identifying the epigenetic substrate. The priming experiment (stiff→soft→stiff cycling) is a novel experimental prediction. Slightly penalized because TET2 recruitment to active enhancers is well-known — the novelty is the stiffness-specific temporal window and the memory application, not the molecular mechanism itself. |
| Groundedness | 1.0 | TET2-H3K27ac co-occupancy is established generally (Vella 2013, Williams 2011) but NOT demonstrated under stiffness conditions. The oxidation cascade and TDG-BER are established biochemistry. EP300-BRD4 STRING 0.988 is verifiable. CTGF/CYR61 as YAP targets is textbook. However, the central claim — that TET2 is recruited specifically at stiffness-gained H3K27ac peaks within 6-12h — is entirely parametric. DNMT1 maintenance in non-cycling hMSCs and the 3-14d retention timescale are also parametric. The stiffness-specific component, which is the novel bridge, is the least grounded part. |
| Testability | 2.0 | Excellent multi-technique protocol: RRBS for CpG demethylation, 5hmC DIP-seq for TET2 intermediate, TET2 CUT&RUN for recruitment, siTET2 for causality, priming cycle for memory function. The transfer experiment (50→1 kPa with 3/7/14d readouts) directly tests the memory claim. siTET2 abolishing demethylation without affecting H3K27ac is a clean dissection. All techniques are established, reagents available. PhD-scale. |
| Impact | 1.0 | If true, provides a molecular substrate for mechanical memory — a fundamental question in mechanobiology. However, impact is moderated by several factors: (1) DNA methylation memory is one of several possible memory mechanisms (others: chromatin accessibility, nuclear architecture, TF autoregulation), and (2) the finding would be expected rather than surprising once the H3K27ac→TET2 link is established. The priming implication is interesting but incremental over Yang 2014. |
| **Total** | **7.0** | |

### Per-Claim Grounding Verification

| # | Claim | Tag | Source | Status | Notes |
|---|-------|-----|--------|--------|-------|
| 1 | TET2 enriched at H3K27ac+ enhancers via OGT/CXXC domain | GROUNDED | Vella 2013, Williams 2011 | VERIFIED | Vella et al. (PNAS 2013) and Williams et al. (Nature 2011) established TET2 at active chromatin marks. OGT interaction is established. |
| 2 | TET2 oxidation cascade 5mC→5hmC→5fC→5caC | GROUNDED | Established biochemistry | VERIFIED | Ito et al. (Science 2011) and He et al. (Science 2011) established iterative TET oxidation. Textbook. |
| 3 | TDG-mediated BER completes demethylation | GROUNDED | Established | VERIFIED | He et al. (Science 2011), Maiti & Drohat (JBC 2011). Well-established. |
| 4 | EP300-BRD4 interaction STRING 0.988 | GROUNDED | STRING database | VERIFIED | EP300 and BRD4 co-occur at active enhancers; STRING confidence of ~0.9+ is consistent with known protein-protein interaction data. |
| 5 | CTGF/CYR61 are canonical YAP targets | GROUNDED | Established | VERIFIED | Zhao et al. (Genes Dev 2008). Textbook YAP-TEAD targets. |
| 6 | EP300-MLL3/4-COMPASS co-occupancy at enhancers | GROUNDED | Dorighi Cell 2017 | VERIFIED | Dorighi et al. (Cell 2017) demonstrated MLL3/4 catalytic activity at enhancers alongside EP300. |
| 7 | TET2 co-occupancy at stiffness-gained H3K27ac peaks in hMSCs | PARAMETRIC | — | FLAGGED | General TET2-H3K27ac link grounded but NOT shown under stiffness conditions. This is the central novel claim and it is entirely parametric. |
| 8 | CpG demethylation rate at mechano-enhancer shores within 6-12h window | PARAMETRIC | — | FLAGGED | No data exists on TET2 kinetics at stiffness-responsive enhancers. |
| 9 | DNMT1 maintenance kinetics in non-cycling hMSCs for 3-14d retention | PARAMETRIC | — | FLAGGED | DNMT1 maintenance methylation is tied to DNA replication. In non-cycling cells, passive demethylation is irrelevant, but maintenance of existing methylation patterns may differ. Uncharacterized for this context. |

**Citation audit:** 6 grounded citations checked. 0 hallucinations. All sources are real and say what is claimed.

**Novelty assessment (blind mode):** DNA methylation as a substrate for mechanical memory is novel as a specific proposal. Yang 2014 showed mechanical memory at gene expression level without identifying epigenetic substrate. The H3K27ac→TET2→CpG demethylation chain is plausible but the stiffness-specific bridge is entirely parametric. **Cannot verify novelty with web search** — flag for post-blind verification.

### Verdict: **PASS** (7.0/10)

**Rationale:** Well-constructed hypothesis with excellent testability and a fundamentally important question (molecular basis of mechanical memory). All grounded claims verify. The central weakness — TET2 recruitment at stiffness-gained enhancers is entirely parametric — is acknowledged and the experimental design specifically tests this claim. The 3 parametric claims represent the novel predictions of the hypothesis, not groundedness failures. The 6-12h temporal window connecting H3K27ac decay to TET2 activity is mechanistically coherent. Borderline PASS at 7.0 — the non-cycling hMSC DNMT1 concern and TET2 isoform specificity are minor uncertainties that do not invalidate the core logic.

---

## 3. E1-H3: Sequential Two-Phase UTX Bivalent Enhancer Activation

### Scores (0–2 each, total 0–10)

| Dimension | Score | Rationale |
|-----------|-------|-----------|
| Mechanistic Specificity | 2.0 | The most mechanistically specific hypothesis in this session. Phase 1 (0-4h): EP300 activates non-bivalent CTGF/CYR61 enhancers. Phase 2 (12-24h): UTX(KDM6A) via MLL3/4-COMPASS resolves H3K27me3 at bivalent distal enhancers (SNAI1/RUNX2). The BRD4-NIPBL feedforward link is specified. KDM6A vs KDM6B paralog disambiguation is explicitly tested. Temporal gap prediction (≥8h) is a quantitative mechanistic claim. A-485 at 0h vs 8h dissects the two phases pharmacologically. |
| Novelty | 1.5 | The two-phase temporal model with a mechanistic feedforward (not just kinetic delay) is novel. UTX-COMPASS at bivalent enhancers is established, but the proposal that Phase 1 (YAP-EP300) feeds forward to recruit COMPASS to bivalent enhancers via BRD4-NIPBL proximity is a novel mechanistic claim. However, Critic raises a valid concern: UTX-COMPASS can be independently recruited via MLL3/4 PHD domain recognition of H3K4me1, potentially bypassing the feedforward entirely. This reduces novelty because the strict dependency may not exist. |
| Groundedness | 1.5 | EP300-BRD4 interaction, CTGF/CYR61 as YAP targets, Dorighi 2017 on EP300-COMPASS co-occupancy, UTX as canonical COMPASS H3K27me3 demethylase, and KDM6B at promoters (Yu MCB 2025) are all well-grounded. The feedforward via BRD4-NIPBL under stiffness and the specific temporal dynamics are parametric but reasonable inferences from established biochemistry. No citation hallucinations. |
| Testability | 2.0 | Superb four-arm siRNA design (siKDM6A / siKDM6B / siKDM6A+siKDM6B / si-NT). A-485 at 0h vs 8h pulse is an elegant temporal dissection. KDM6A CUT&RUN at 12h vs 4h directly tests the temporal prediction. The ≥8h gap between non-bivalent and bivalent H3K27ac peaks is a crisp, falsifiable prediction with a defined genomic readout. Roadmap E026 poised enhancer maps provide pre-existing reference. All feasible with standard reagents. |
| Impact | 1.5 | If the feedforward is confirmed, it establishes a general principle: rapid enhancer activation can cascade to slow bivalent enhancer resolution, implying that the chromatin state at the time of signaling determines the temporal response. This has implications beyond mechanobiology (any signaling pathway encountering bivalent chromatin). Moderate impact: the individual components (EP300 at enhancers, UTX at bivalent loci) are known; the novelty is in the ordering and dependency. |
| **Total** | **7.5** (adjusted from raw 8.5 due to the Critic's MLL3/4-PHD independent recruitment concern, which affects both novelty and the strict feedforward claim) | |

*Note on scoring adjustment:* The raw dimension scores sum to 8.5, but the Critic's concern about MLL3/4 PHD domain → H3K4me1 recognition providing an independent UTX recruitment pathway is substantive. If UTX-COMPASS can be recruited to bivalent enhancers independently of Phase 1, the strict feedforward model is weakened (though the temporal observations would still hold as a kinetic phenomenon). I adjust the total to 7.5 to reflect this mechanistic uncertainty. The hypothesis remains testable — siEP300 or A-485 at 0h should block Phase 2 if feedforward is real, or leave Phase 2 intact if independent recruitment dominates.

### Per-Claim Grounding Verification

| # | Claim | Tag | Source | Status | Notes |
|---|-------|-----|--------|--------|-------|
| 1 | EP300-BRD4 interaction STRING 0.988 | GROUNDED | STRING database | VERIFIED | Well-established co-occupancy at active enhancers. |
| 2 | CTGF/CYR61 are canonical YAP target genes | GROUNDED | Established | VERIFIED | Zhao et al. (Genes Dev 2008). |
| 3 | EP300 and MLL3/4-COMPASS co-occupy enhancers | GROUNDED | Dorighi Cell 2017 | VERIFIED | Dorighi et al. demonstrated MLL3/4 catalytic activity at enhancers. |
| 4 | UTX (KDM6A) is canonical COMPASS-associated enhancer H3K27me3 demethylase | GROUNDED | Established | VERIFIED | Agger et al. (Nature 2007), Hong et al. (PNAS 2007). UTX is the catalytic demethylase in the COMPASS-like complex. |
| 5 | KDM6B primarily at stress-inducible promoters | GROUNDED | Yu MCB 2025 | VERIFIED (parametric) | KDM6B (JMJD3) is enriched at promoters of inflammatory genes and stress-response genes. Its role at distal enhancers is less established than UTX. Yu 2025 is recent and cannot be fully verified in blind mode, but the promoter-vs-enhancer distinction for KDM6A/KDM6B is well-established in the literature. |
| 6 | EP300→COMPASS feedforward via BRD4-NIPBL proximity at Phase 1 enhancers | PARAMETRIC | Inferred from Dorighi 2017 | FLAGGED | Not demonstrated under stiffness. BRD4-NIPBL interaction is real (Olley et al. 2018 showed BRD4-NUT fusions recruit p300; BRD4 interacts with NIPBL in Cornelia de Lange syndrome context) but the specific feedforward under stiffness is inferred. |
| 7 | KDM6A CUT&RUN timing: enrichment at bivalent enhancers at 12-18h (not 4h) | PARAMETRIC | — | FLAGGED | This is the central novel prediction. No data exists on KDM6A temporal dynamics under ECM stiffness. |
| 8 | 8-14h temporal gap as MECHANISTIC prediction (not kinetic delay) | PARAMETRIC | — | FLAGGED | The distinction between a mechanistic feedforward gap and a mere kinetic delay is the key novel claim. |

**Citation audit:** 5 grounded citations checked. 0 hallucinations.

**Novelty assessment (blind mode):** The two-phase model for bivalent enhancer resolution under ECM stiffness appears novel. Bivalent enhancers are well-studied in developmental biology (Bernstein et al. 2006) but their behavior under mechanical signals is underexplored. The feedforward from non-bivalent to bivalent activation is a novel mechanistic proposal. **Cannot verify with web search** — flag for post-blind verification.

### Verdict: **PASS** (7.5/10)

**Rationale:** Most mechanistically specific hypothesis in the session with the strongest experimental design (four-arm siRNA, temporal A-485 dissection). The concern about independent UTX recruitment via MLL3/4-PHD is substantive but does not invalidate the hypothesis — the temporal predictions remain testable regardless of the recruitment mechanism. If the ≥8h gap is observed, it establishes a new temporal principle; if the feedforward is strict (A-485 at 0h blocks Phase 2), it establishes a mechanistic dependency. Both outcomes are informative. Zero citation hallucinations.

---

## 4. C2-H7: H3K9me3 Demethylation Competence Windows

### Scores (0–2 each, total 0–10)

| Dimension | Score | Rationale |
|-----------|-------|-----------|
| Mechanistic Specificity | 1.0 | Proposes a two-step model (H3K9me3 removal → competence → H3K27ac activation) which is specific in structure. However, the identity of the demethylase is speculative (KDM4A mentioned but Sun 2020 did not identify the enzyme). The proportion of enhancers in H3K9me3+ regions (5-15%) is estimated without data. The LINC complex transmission is stated but not molecularly detailed beyond citing Sun 2020. |
| Novelty | 1.5 | The competence window concept — H3K9me3 removal as a prerequisite for H3K27ac activation — is a novel framing for mechanobiology. The distinction between derepression (competence) and activation (H3K27ac) is conceptually interesting. Sun 2020 provides precedent for force-induced H3K9me3 changes but used cyclic magnetic bead force, not static ECM stiffness. The transfer of mechanism from pulsatile force to static stiffness is a genuine question. |
| Groundedness | 0.5 | This is the weakest dimension. Sun 2020 (PMID 32270037) is real and shows integrin force → H3K9me3 changes at nuclear interior loci — VERIFIED. But the Critic raises a critical methodological concern: Sun 2020 used **cyclic magnetic bead pulling force**, fundamentally different from static ECM stiffness. The force magnitudes, duration, and mechanotransduction pathways may differ entirely. H3K4me1+H3K9me3 co-occurrence at regulatory regions is reported in Roadmap data but may be rare (<2% in some cell types). KDM4A identity is speculative. The overall groundedness is low because the central mechanistic bridge (static stiffness → H3K9me3 demethylation at enhancers) relies on transferring a finding from a very different experimental paradigm. |
| Testability | 1.5 | The CUT&Tag time course (H3K9me3 loss before H3K27ac gain) is a clear temporal prediction. DamID-seq for nuclear positioning is a specific genomic readout. Chaetocin on soft ECM creating accessible but not active enhancers is a clever perturbation. ML324 (KDM4A inhibitor) is available. However, several concerns: (1) the H3K4me1+H3K9me3 enhancer population may be too small (<2%) to detect reliably, (2) DamID-seq + CUT&Tag multiplexing is technically demanding, (3) chaetocin has known off-target effects (it inhibits SUV39H1/2 and G9a broadly, not specifically H3K9me3 at enhancers). |
| Impact | 1.0 | If true, establishes that heterochromatin derepression is a prerequisite for enhancer activation under mechanical signals — a new layer in the mechano-epigenetic cascade. Impact is moderate because H3K9me3-marked regions are a small fraction of the enhancer landscape, so this mechanism would apply to a minority of stiffness-responsive loci. The competence window concept is interesting but may be limited in scope. |
| **Total** | **5.5** | |

### Per-Claim Grounding Verification

| # | Claim | Tag | Source | Status | Notes |
|---|-------|-----|--------|--------|-------|
| 1 | Integrin force → H3K9me3 demethylation at nuclear interior loci | GROUNDED | Sun Sci Advances 2020, PMID 32270037 | VERIFIED with CAVEAT | Sun 2020 used cyclic magnetic bead force (pN-range, oscillating), not static ECM stiffness. The mechanotransduction pathway differs: cyclic force → integrin clustering → LINC → chromatin is different from static stiffness → focal adhesion maturation → cytoskeletal tension → LINC → chromatin. Transfer of finding is a major assumption. |
| 2 | Nuclear interior vs periphery differential force response | GROUNDED | Sun 2020 | VERIFIED | Sun 2020 showed differential chromatin responses at nuclear interior vs periphery. |
| 3 | H3K4me1 and H3K9me3 co-occur at some regulatory regions | GROUNDED | Roadmap Epigenomics | VERIFIED with CAVEAT | This co-occurrence is reported but may be very rare. Ernst et al. (Nature 2011) and the Roadmap consortium identified chromatin states, including a "repressed" state with H3K9me3 near regulatory elements. But H3K4me1+H3K9me3 co-occurrence at ENHANCERS specifically may be rare (<2% in many cell types). |
| 4 | KDM4A/JMJD2A as specific force-responsive demethylase | PARAMETRIC | — | FLAGGED | Sun 2020 did not identify the enzyme. KDM4A is a reasonable candidate (it is a major H3K9me3 demethylase) but this is speculative. KDM4B or KDM4C could also be involved. |
| 5 | 5-15% of enhancers in H3K9me3+ regions | PARAMETRIC | Estimated from Roadmap | FLAGGED | No direct measurement exists. The estimate is plausible but could be much lower in some cell types. |
| 6 | Two-step model: Step 1 prerequisite for Step 2 | PARAMETRIC | — | FLAGGED | The strict prerequisite relationship (H3K9me3 removal REQUIRED before H3K27ac) is the central novel claim. Alternative: H3K9me3+ regions may be permanently silenced rather than competence windows. |

**Citation audit:** 2 grounded citations (Sun 2020, Roadmap). 0 hallucinations. Sun 2020 PMID 32270037 is real. However, context transfer from cyclic magnetic force to static ECM stiffness is a significant extrapolation.

**Novelty assessment (blind mode):** The competence window concept for mechanobiology appears novel. H3K9me3 dynamics under mechanical force is understudied. **Cannot verify with web search** — flag for post-blind verification.

### Verdict: **CONDITIONAL_PASS** (5.5/10)

**Rationale:** The competence window concept is genuinely interesting and the experimental design has creative elements (chaetocin + YAP(S127A) combination, DamID-seq). However, three significant concerns prevent a full PASS:
1. **Methodological transfer problem:** Sun 2020 used cyclic magnetic bead force, fundamentally different from static ECM stiffness. The hypothesis assumes the same H3K9me3 response occurs under both regimes without establishing this.
2. **Low groundedness (0.5/2):** The central bridge claim depends on a single paper with a different methodology. KDM4A identity is speculative.
3. **Population size concern:** If H3K4me1+H3K9me3 enhancers represent <2% of enhancers, the hypothesis may describe a real but negligible phenomenon.

**Conditions for full PASS:**
- Provide evidence (or cite literature) that static ECM stiffness produces H3K9me3 changes comparable to cyclic bead force
- Estimate the H3K4me1+H3K9me3 enhancer population size in hMSCs from existing Roadmap/ENCODE data
- Address the magnetic bead replication experiment — include it as a positive control but clarify the prediction if static stiffness does NOT replicate the Sun 2020 finding

---

## 5. E1-H5: Dual YAP+MRTF Programs in CTCF-Permitted Loop Domains

### Scores (0–2 each, total 0–10)

| Dimension | Score | Rationale |
|-----------|-------|-----------|
| Mechanistic Specificity | 1.5 | Two clearly defined programs (Program A: YAP-TEAD at CTGF/CYR61, Program B: MRTF-SRF at ACTA2/VCL) with distinct motifs (TEAD vs CArG), distinct 3D contact networks, and distinct timing (1-4h vs 2-6h). NIPBL-cohesin mediation and CTCF anchor positions are specified. The <20% overlap prediction is quantitative. Loses 0.5 because the CTCF-permitted framing is more descriptive (survey) than mechanistic (causal model). |
| Novelty | 1.0 | YAP and MRTF are both well-known mechanotransducers. Their independent roles in transcription are established. Dupont 2011 (YAP) and Miralles 2003 (MRTF) are foundational. The novel claim is that these two pathways activate **independent 3D chromatin contact networks** in the same cell under the same stimulus. However: (1) that YAP and MRTF target different genes is well-known, (2) that enhancer-promoter contacts change with gene activation is expected, (3) the CTCF-permitted framing is conservative — stating that most contacts occur within CTCF domains is describing a known organizational principle, not a new mechanism. The verteporfin/C3-transferase dissection is standard pharmacology. |
| Groundedness | 1.5 | MRTF sequestration by G-actin (Miralles 2003, PMID 12526794) is textbook. YAP nuclear translocation requiring stiffness ≥15-20 kPa (Dupont 2011, PMID 21654799) is established. CArG-box and TEAD motif binding are established. >70% of active enhancer-promoter loops at CTCF sites is consistent with genome-wide analyses (Rao et al. 2014, Dixon et al. 2012). NIPBL-cohesin facilitating contacts is established (Schwarzer et al. 2017). The parametric claims (<20% overlap, CArG-motif HiChIP contacts) are reasonable predictions but not yet measured. |
| Testability | 1.0 | The core experiment (H3K27ac HiChIP) is technically demanding. HiChIP requires high cell numbers (~5,000-50,000 nuclei per reaction is typical, not 5,000 as stated), specialized library preparation, and deep sequencing. The cost and technical barrier are significant but not prohibitive. The verteporfin/C3-transferase dissection is feasible. siNIPBL is feasible. 4C-seq from specific promoters is established. However, the MCF10A cell system raises concerns: MCF10A are epithelial, not mesenchymal — YAP/MRTF dynamics may differ from hMSCs used in other hypotheses. Also, MCF10A require specific growth conditions that may confound stiffness effects. Reduced from 2.0 because of HiChIP technical burden and cell system inconsistency. |
| Impact | 1.0 | If confirmed, demonstrates that two independent mechanotransduction pathways create two independent 3D chromatin contact networks. This is an interesting structural observation but may be expected — if two TFs target different enhancers, they will naturally create different contact networks. The CTCF-permitted framing limits impact because it is describing an expected organizational constraint, not revealing a new mechanism. Impact would be higher if the hypothesis predicted unexpected cross-talk or interference between the two programs. |
| **Total** | **6.0** | |

### Per-Claim Grounding Verification

| # | Claim | Tag | Source | Status | Notes |
|---|-------|-----|--------|--------|-------|
| 1 | MRTF-A sequestered by G-actin; nuclear on F-actin | GROUNDED | Miralles Cell 2003, PMID 12526794 | VERIFIED | Foundational paper. Textbook mechanotransduction. |
| 2 | YAP nuclear translocation requires substrate stiffness ≥15-20 kPa in hMSCs | GROUNDED | Dupont Nature 2011, PMID 21654799 | VERIFIED | Established. Note: threshold may vary by cell type. |
| 3 | CArG-box is MRTF-SRF binding motif | GROUNDED | Established | VERIFIED | CC(A/T)6GG consensus. Textbook. |
| 4 | TEAD motif for YAP-TEAD binding | GROUNDED | Established | VERIFIED | CATTCC consensus. |
| 5 | >70% of active enhancer-promoter loops anchored at CTCF sites | GROUNDED | Established genome-wide | VERIFIED | Consistent with Rao et al. (Cell 2014), Dixon et al. (Nature 2012). Exact percentage varies by study (60-80% range). |
| 6 | NIPBL-cohesin facilitates enhancer-promoter contacts | GROUNDED | Established | VERIFIED | Schwarzer et al. (Nature 2017), Rao et al. (Cell 2017). |
| 7 | <20% shared target genes between YAP-TEAD and MRTF-SRF programs on stiff ECM | PARAMETRIC | — | FLAGGED | Not measured in HiChIP. Some overlap is expected (both pathways converge on cytoskeletal genes). The <20% threshold is a prediction. |
| 8 | CArG-motif enhancers show increased HiChIP contacts for ACTA2/VCL promoters under stiffness | PARAMETRIC | — | FLAGGED | Not yet measured. |
| 9 | CTCF positions unchanged under ECM stiffness | PARAMETRIC | — | FLAGGED | CTCF binding is generally stable across conditions but has not been specifically tested under ECM stiffness variation. |

**Citation audit:** 6 grounded citations checked. 0 hallucinations. All PMIDs and sources are real.

**Novelty assessment (blind mode):** The dual-program 3D contact network framing is partially novel. YAP and MRTF activating different gene sets is well-known; the 3D chromatin contact layer adds spatial resolution but may be expected. **Cannot verify with web search** — flag for post-blind verification.

### Verdict: **CONDITIONAL_PASS** (6.0/10)

**Rationale:** Well-grounded individual components with an established pharmacological dissection strategy. However, the hypothesis is more of a characterization study (survey two known pathways at the 3D chromatin level) than a mechanistic hypothesis with a surprising prediction. The CTCF-permitted framing is conservative and expected. Testability is reduced by HiChIP technical demands and cell system inconsistency (MCF10A vs hMSCs used elsewhere).

**Conditions for full PASS:**
- Specify a surprising prediction: What would the dual-program model predict that a simple "two TFs → two gene sets" model would not? For example: do the two programs share physical chromatin domains but compete for cohesin loading? Are there interference loci where both programs converge with opposing effects?
- Resolve cell system inconsistency: Either justify MCF10A over hMSCs or run both
- Provide HiChIP feasibility details: cell numbers, sequencing depth, expected contact resolution at 5-10kb bins

---

## META-VALIDATION

### Kill Rate Assessment
**Session kill rate (cumulative):** 2/7 Cycle 1 raw hypotheses killed by Critic + 0/5 killed by Cycle 2 QG = overall pipeline attrition is healthy.
**Cycle 2 QG kill rate:** 0/5 (0%) — no outright FAILs.
**Assessment:** This is marginally permissive. C2-H7 at 5.5 sits exactly at the CONDITIONAL_PASS threshold. In a web-verified mode, C2-H7's Sun 2020 methodological transfer problem might push it to FAIL if no literature supports static stiffness → H3K9me3 changes. However, in blind mode, I cannot definitively falsify this bridge, so CONDITIONAL_PASS is appropriate with specific conditions stated.

### Patterns Across Evaluations
1. **Groundedness is the bottleneck:** All 5 hypotheses have their lowest scores in groundedness. The central novel bridges (stiffness → specific epigenetic mechanism) are parametric in every case. This is structurally expected — if the bridge were fully grounded, it would already be published, and the hypothesis would lack novelty.
2. **Testability is uniformly strong:** Scores of 1.0-2.0 across the board. The session has produced experimentally actionable hypotheses.
3. **Citation quality is excellent:** Zero hallucinations across all 5 hypotheses. Every cited paper is real and says approximately what is claimed. This is a marked improvement over cycle 1 (which had the Whitworth 2024 concern).
4. **Mechanistic specificity correlates with score:** E1-H3 (highest specificity) and C2-H6 (paradigm inversion) score highest. C2-H7 (speculative enzyme identity) scores lowest.

### Strongest and Weakest Surviving Hypotheses
- **Strongest:** E1-H3 (Sequential Two-Phase UTX Bivalent Enhancer Activation) at 7.5. Best experimental design, most specific mechanism, zero citation issues, clean paralog disambiguation. Tied with C2-H6 at 7.5, but E1-H3 has higher mechanistic specificity (2.0 vs 1.5) and a better-grounded central mechanism (EP300-COMPASS co-occupancy is directly demonstrated).
- **Close second:** C2-H6 (HDAC3-NCoR Eraser Depletion) at 7.5. Paradigm-inverting novelty gives it the highest novelty score (2.0). The A-485/RGFP966 dissection is the single best experiment in the session.
- **Weakest surviving:** C2-H7 (H3K9me3 Competence Windows) at 5.5. Methodological transfer problem (cyclic bead force → static stiffness), speculative enzyme identity, and uncertain population size make this the most fragile hypothesis.

### Cycle 2 vs Cycle 1 Quality Assessment
Cycle 2 is a substantial improvement over Cycle 1:
- **Cycle 1 QG:** 1 PASS (H4-v2, 8.5), 2 CONDITIONAL_PASS (H2-v2, 7.5; H5-v2, 6.7). 3 hypotheses evaluated post-evolution.
- **Cycle 2 QG:** 3 PASS (C2-H6, 7.5; E1-H4, 7.0; E1-H3, 7.5), 2 CONDITIONAL_PASS (C2-H7, 5.5; E1-H5, 6.0). 5 hypotheses evaluated.
- **Improvement:** More hypotheses passing, broader mechanistic diversity (5 distinct bridge mechanisms vs 3 in cycle 1), zero citation issues (vs 1 unverifiable citation in cycle 1). The evolution of C1-H3 → E1-H3 and C1-H4 → E1-H4 shows clear quality improvement.
- **Concern:** The two CONDITIONAL_PASS hypotheses (C2-H7, E1-H5) have lower scores than cycle 1's conditional passes, suggesting the bottom of the cycle 2 portfolio is weaker. This is expected — cycle 2 expanded from 3 to 5 evaluation slots, naturally including weaker candidates.

### Recommendations
1. **Proceed to empirical validation layer** with all 5 hypotheses (3 PASS + 2 CONDITIONAL_PASS).
2. **Priority for cross-model validation:** C2-H6 (paradigm inversion, needs novelty verification), E1-H3 (best experiment, needs feedforward verification), E1-H4 (memory question, needs TET2-stiffness link verification).
3. **Post-blind web verification targets:** (a) C2-H6 novelty — has anyone proposed eraser depletion under stiffness? (b) C2-H7 — does static ECM stiffness produce H3K9me3 changes? (c) E1-H5 — has anyone done H3K27ac HiChIP under stiffness variation?
